Table 2.
Indication | Number of patients |
---|---|
CSME | 221 (61.55%) |
PDR with VH | 23 (6.40%) |
CNV | 59 (16.43%) |
CRVO | 28 (7.79%) |
BRVO | 23 (6.40%) |
NVG | 4 (1.11%) |
Parafoveal Telangiectasia | 1 (0.27%) |
CSME = Clinically Significant Macular Edema, PDR = Proliferative Diabetic Retinopathy, CNV = Choroidal neovascularization, CRVO = Central Retinal Vein Occlusion, BRVO = Branch Retinal Vein Occlusion, NVG = Neovascular Glaucoma